CBCT Assessment of Marginal Bone Changes With Ozone Therapy (ozone-ımplant)
13 september 2026 bijgewerkt door: Zeliha Başak Çakır Erdil, Adiyaman University
CBCT Assessment of Peri-Implant Marginal Bone Changes Following Adjunctive Local Ozone Therapy: A Randomized Split-Mouth Clinical Trial
This study examined whether adding local gaseous ozone to standard dental implant treatment could reduce early bone loss around implants.
Fifty adults requiring matched implants on opposite sides of the same jaw participated.
Within each participant, matched implant sites were randomly assigned to ozone treatment or standard treatment without ozone.
Ozone was applied to the prepared implant socket during surgery and to the peri-implant surgical site after suturing and on postoperative days 1, 3, 5, and 7. Changes in marginal bone levels from baseline to 6 months were assessed using cone-beam computed tomography (CBCT).
Studie Overzicht
Toestand
Voltooid
Interventie / Behandeling
Gedetailleerde beschrijving
This prospective, split-mouth randomized clinical trial was conducted at the Department of Periodontology, Faculty of Dentistry, Adıyaman University.
Participants required implant placement at matched contralateral posterior sites within the same jaw.
Within each participant, matched implant sites were randomly allocated to adjunctive local gaseous ozone treatment or standard treatment without ozone.
Ozone was applied to the prepared implant socket during surgery and to the peri-implant surgical site after suturing and on postoperative days 1, 3, 5, and 7. Fifty participants were enrolled; two were lost to follow-up, and 48 participants with 152 implants completed the study.
The final analysis included 76 ozone-treated and 76 control implants.
The primary outcome was the change in peri-implant marginal bone level from baseline to 6 months, assessed using cone-beam computed tomography at the buccal, palatal/lingual, mesial, and distal implant surfaces.
The outcome assessor was blinded to treatment allocation.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
50
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Merkez
-
Adıyaman, Merkez, Turkije (Türkiye), 02030
- Faculty of Dentistry, Adıyaman University
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- Adults aged 18 to 65 years.
- Systemically healthy individuals.
- Ability to comply with the study procedures and follow-up visits.
- Requirement for implant placement at matched contralateral posterior sites within the same jaw.
- Healed edentulous sites suitable for conventional implant placement.
- Adequate alveolar bone volume for placement of implants measuring 3.5-4.0 mm in diameter and 8-12 mm in length without the need for advanced bone augmentation, with at least 1.5 mm of surrounding bone.
- Initial soft-tissue thickness of at least 2 mm and keratinized mucosal width of at least 2 mm at the implant sites.
- Provision of written informed consent.
Exclusion Criteria:
- Systemic diseases or medical conditions contraindicating implant surgery.
- Pregnancy.
- Smoking.
- Active oral infection or advanced periodontal disease.
- Insufficient bone volume requiring advanced bone augmentation.
- Incomplete healing at the intended implant site following recent tooth extraction.
- Previous implant failure at the intended implant site.
- Any contraindication to ozone therapy.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Gaseous Ozone Application
Within each participant, one or more matched implant sites were randomly allocated to adjunctive local gaseous ozone treatment.
Ozone was applied to the surgically prepared implant socket before implant placement and to the peri-implant surgical site after suturing and on postoperative days 1, 3, 5, and 7.
All sites also received standard surgical and postoperative care.
|
Gaseous ozone was applied to the surgically prepared implant socket before implant placement.
Following suturing, ozone was applied locally to the peri-implant surgical site and was repeated on postoperative days 1, 3, 5, and 7.
|
|
Actieve vergelijker: Conventional Implant Placement
Within each participant, the corresponding contralateral matched implant site or sites were allocated to the control treatment.
These sites received conventional implant placement and standard postoperative care without ozone application at any time point.
|
Implants were placed using the standard surgical protocol, followed by standard postoperative care, without intraoperative or postoperative ozone application.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Marginal Bone Level Around Dental Implants
Tijdsspanne: Baseline and 6 months after implant placement
|
Using cone-beam computed tomography (CBCT), the vertical distance from the implant shoulder to the first bone-to-implant contact was measured in millimeters at the buccal, palatal/lingual, mesial, and distal surfaces at baseline and 6 months.
For each surface, marginal bone level change was calculated as the 6-month distance minus the baseline distance; positive values indicated greater marginal bone loss.
Combined buccolingual and mesiodistal measurements were calculated by averaging the corresponding surface measurements.
Changes were compared between matched ozone-treated and control implant sites.
|
Baseline and 6 months after implant placement
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: METİN ÇALIŞIR, PhD, Department of Periodontology, Faculty of Dentistry, Adıyaman University, Adıyaman, Turkey
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
3 september 2025
Primaire voltooiing (Werkelijk)
18 mei 2026
Studie voltooiing (Werkelijk)
18 mei 2026
Studieregistratiedata
Eerst ingediend
30 juni 2026
Eerst ingediend dat voldeed aan de QC-criteria
30 juni 2026
Eerst geplaatst (Werkelijk)
7 juli 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
16 september 2026
Laatste update ingediend die voldeed aan QC-criteria
13 september 2026
Laatst geverifieerd
1 september 2026
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- HRU-25.14.63
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Beschrijving IPD-plan
Individual participant data will not be shared because the informed consent obtained from participants did not include external sharing of individual-level data.
Aggregated study findings will be reported in the publication.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .